Aprea Therapeutics 過去の業績
過去 基準チェック /06
Aprea Therapeutics has been growing earnings at an average annual rate of 33.2%, while the Biotechs industry saw earnings growing at 19% annually. Revenues have been growing at an average rate of 410.9% per year.
主要情報
33.2%
収益成長率
54.1%
EPS成長率
| Biotechs 業界の成長 | 17.0% |
| 収益成長率 | 410.9% |
| 株主資本利益率 | -48.1% |
| ネット・マージン | -1,013.4% |
| 前回の決算情報 | 30 Jun 2024 |
収支内訳
Aprea Therapeutics の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 1 | -13 | 7 | 0 |
| 31 Mar 24 | 1 | -13 | 7 | 0 |
| 31 Dec 23 | 1 | -14 | 8 | 0 |
| 30 Sep 23 | 1 | -13 | 9 | 16 |
| 30 Jun 23 | 0 | -14 | 6 | 0 |
| 31 Mar 23 | 0 | -109 | 20 | -4 |
| 31 Dec 22 | 0 | -113 | 21 | 0 |
| 30 Sep 22 | 0 | -118 | 22 | 4 |
| 30 Jun 22 | 0 | -123 | 26 | 10 |
| 31 Mar 22 | 0 | -35 | 14 | 21 |
| 31 Dec 21 | 0 | -37 | 14 | 0 |
質の高い収益: APRE is currently unprofitable.
利益率の向上: APRE is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: APRE is unprofitable, but has reduced losses over the past 5 years at a rate of 33.2% per year.
成長の加速: Unable to compare APRE's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: APRE is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-2.3%).
株主資本利益率
高いROE: APRE has a negative Return on Equity (-48.11%), as it is currently unprofitable.